Hao-Yuan Mo

4.2k total citations
34 papers, 1.3k citations indexed

About

Hao-Yuan Mo is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Hao-Yuan Mo has authored 34 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Otorhinolaryngology, 18 papers in Oncology and 15 papers in Surgery. Recurrent topics in Hao-Yuan Mo's work include Head and Neck Cancer Studies (19 papers), Head and Neck Surgical Oncology (11 papers) and Viral-associated cancers and disorders (9 papers). Hao-Yuan Mo is often cited by papers focused on Head and Neck Cancer Studies (19 papers), Head and Neck Surgical Oncology (11 papers) and Viral-associated cancers and disorders (9 papers). Hao-Yuan Mo collaborates with scholars based in China, United States and Singapore. Hao-Yuan Mo's co-authors include Chao-Nan Qian, Hai-Qiang Mai, Ming‐Huang Hong, Qiu-Yan Chen, Pei‐Yu Huang, Fang Qiu, Ka-Jia Cao, Xiang Guo, Yi-Xin Zeng and Mu‐Sheng Zeng and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Hao-Yuan Mo

34 papers receiving 1.3k citations

Peers

Countries citing papers authored by Hao-Yuan Mo

Since Specialization

Citations

This map shows the geographic impact of Hao-Yuan Mo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hao-Yuan Mo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hao-Yuan Mo more than expected).

Fields of papers citing papers by Hao-Yuan Mo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hao-Yuan Mo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hao-Yuan Mo. The network helps show where Hao-Yuan Mo may publish in the future.

Co-authorship network of co-authors of Hao-Yuan Mo

This figure shows the co-authorship network connecting the top 25 collaborators of Hao-Yuan Mo. A scholar is included among the top collaborators of Hao-Yuan Mo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hao-Yuan Mo. Hao-Yuan Mo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Association between Pretreatment Serum High-density Lipoprotein Cholesterol and Treatment Outcomes in Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy: Findings from a Randomised Trial 2019 ·Journal of Cancer ·(unknown), Ming‐Yuan Chen, Xiang Guo, Ling Guo, Hao-Yuan Mo, Chao-Nan Qian, Bixiu Wen, Ming‐Huang Hong, Pei‐Yu Huang	8
2	Efficacy of controlled-release oxycodone for reducing pain due to oral mucositis in nasopharyngeal carcinoma patients treated with concurrent chemoradiotherapy: a prospective clinical trial 2019 ·Supportive Care in Cancer ·Xin Hua, (unknown), Qian Zhu, Wen Hu, Chao Lin, (unknown), Wen Wen, (unknown), (unknown), Qiu-Yan Chen, Dong-Hua Luo, Rui Sun, Hao-Yuan Mo, Lin-Quan Tang, Wen-wen Zhang, Zhen‐Yu He, Hai‐Qiang Mai, Huan-Xin Lin, Ling Guo	16
3	Beneficial effects of anti-EGFR agents, Cetuximab or Nimotuzumab, in combination with concurrent chemoradiotherapy in advanced nasopharyngeal carcinoma 2018 ·Oral Oncology ·Mei Lin, Rui You, You-Ping Liu, (unknown), Hao-Jiong Zhang, Xiong Zou, Qi Yang, Chao-Feng Li, Yi-Jun Hua, Tao Yu, (unknown), Jibin Li, Hao-Yuan Mo, Ling Guo, Ai-Hua Lin, Ying Sun, Chao-Nan Qian, Jun Ma, Hai-Qiang Mai, Ming‐Yuan Chen	21
4	Concurrent chemoradiotherapy with or without cetuximab for stage II to IVb nasopharyngeal carcinoma: a case–control study 2017 ·BMC Cancer ·(unknown), Qiu-Yan Chen, Lin-Quan Tang, Li-Ting Liu, Shan-Shan Guo, Ling Guo, Hao-Yuan Mo, Ming‐Yuan Chen, Xiang Guo, Ka-Jia Cao, Chao-Nan Qian, (unknown), Jin‐Xin Bei, Jian‐Yong Shao, Ying Sun, Jing Tan, Shuai Chen, Jun Ma, Chong Zhao, Hai-Qiang Mai	22
5	The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients 2017 ·Cancer Research and Treatment ·Li-Ting Liu, Qiu-Yan Chen, Lin-Quan Tang, Shan-Shan Guo, Ling Guo, Hao-Yuan Mo, Ming‐Yuan Chen, Chong Zhao, Xiang Guo, Chao-Nan Qian, Mu‐Sheng Zeng, Jin‐Xin Bei, Jing Tan, Shuai Chen, Ming‐Huang Hong, Jian‐Yong Shao, Ying Sun, Jun Ma, Hai‐Qiang Mai	61
6	An extended genome-wide association study identifies novel susceptibility loci for nasopharyngeal carcinoma 2016 ·Human Molecular Genetics ·Qian Cui, Qi-Sheng Feng, Hao-Yuan Mo, (unknown), Yun-Fei Xia, Hong‐Xing Zhang, Jia Nee Foo, Yun-Miao Guo, Li-Zhen Chen, Ming Li, Wensheng Liu, Miao Xu, Gangqiao Zhou, Fuchu He, Xueqing Yu, Wei-Hua Jia, Jianjun Liu, Yi-Xin Zeng, Jin‐Xin Bei	30
7	Prognostic effect of pregnancy on young female patients with nasopharyngeal carcinoma: results from a matched cohort analysis 2016 ·Oncotarget ·Lu Zhang, Huai Liu, Lin-Quan Tang, Qiu-Yan Chen, Shan-Shan Guo, Li-Ting Liu, Ling Guo, Hao-Yuan Mo, Chong Zhao, Xiang Guo, Ka-Jia Cao, Chao-Nan Qian, Mu‐Sheng Zeng, Jian‐Yong Shao, Ying Sun, Jun Ma, Ming‐Huang Hong, Hai-Qiang Mai	4
8	Ten-year outcomes of a randomised trial for locoregionally advanced nasopharyngeal carcinoma: A single-institution experience from an endemic area 2015 ·European Journal of Cancer ·Pei‐Yu Huang, Qi Zeng, Ka-Jia Cao, Xiang Guo, Ling Guo, Hao-Yuan Mo, Peihong Wu, Chao-Nan Qian, Hai-Qiang Mai, Ming‐Huang Hong	40
9	Different Prognostic Values of Plasma Epstein-Barr Virus DNA and Maximal Standardized Uptake Value of 18F-FDG PET/CT for Nasopharyngeal Carcinoma Patients with Recurrence 2015 ·PLoS ONE ·Ting Shen, (unknown), Dong-Hua Luo, Qiu-Yan Chen, (unknown), (unknown), (unknown), Li-Ting Liu, Chao-Nan Qian, Xiang Guo, Mu‐Sheng Zeng, Hao-Yuan Mo, Hai-Qiang Mai	27
10	Randomized study of sinusoidal chronomodulated versus flat intermittent induction chemotherapy with cisplatin and 5-fluorouracil followed by traditional radiotherapy for locoregionally advanced nasopharyngeal carcinoma 2013 ·Chinese Journal of Cancer ·Huan-Xin Lin, Yi-Jun Hua, Qiu-Yan Chen, Dong-Hua Luo, Rui Sun, Fang Qiu, Hao-Yuan Mo, Hai-Qiang Mai, Xiang Guo, (unknown), Ming‐Huang Hong, Ling Guo	23
11	The independent, unfavorable prognostic factors endothelin A receptor and chemokine receptor 4 have a close relationship in promoting the motility of nasopharyngeal carcinoma cells via the activation of AKT and MAPK pathways 2013 ·Journal of Translational Medicine ·Dong-Hua Luo, Qiu-Yan Chen, Huai Liu, Lihua Xu, Hui-Zhong Zhang, Lu Zhang, Lin-Quan Tang, Hao-Yuan Mo, Pei‐Yu Huang, Xiang Guo, Hai‐Qiang Mai	14
12	Elevated Serum Endostatin Levels are Associated with Poor Survival in Patients with Advanced-stage Nasopharyngeal Carcinoma 2013 ·Clinical Oncology ·Hao-Yuan Mo, Dong-Hua Luo, (unknown), Huai Liu, Qiu-Yan Chen, Lin-Quan Tang, (unknown), Pei‐Yu Huang, (unknown), Changqing Zhang, Ying Zhang, Hai-Qiang Mai	12
13	Pretreatment body mass index as an independent prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy: Findings from a randomised trial 2013 ·European Journal of Cancer ·Pei‐Yu Huang, (unknown), Ka-Jia Cao, Xiang Guo, Ling Guo, Hao-Yuan Mo, Bixiu Wen, Yi-Shan Wu, Hai-Qiang Mai, Ming‐Huang Hong	60
14	A randomized trial of induction chemotherapy plus concurrent chemoradiotherapy versus induction chemotherapy plus radiotherapy for locoregionally advanced nasopharyngeal carcinoma 2012 ·Oral Oncology ·Pei‐Yu Huang, Ka-Jia Cao, Xiang Guo, Hao-Yuan Mo, Ling Guo, Yan‐Qun Xiang, (unknown), Fang Qiu, Su-Mei Cao, Ying Guo, Li Zhang, (unknown), Rui Sun, Qiu-Yan Chen, Dong-Hua Luo, Yi-Jun Hua, Hai-Qiang Mai, Ming‐Huang Hong	58
15	Tumor Microenvironment Macrophage Inhibitory Factor Directs the Accumulation of Interleukin-17-producing Tumor-infiltrating Lymphocytes and Predicts Favorable Survival in Nasopharyngeal Carcinoma Patients 2012 ·Journal of Biological Chemistry ·Jiang Li, Hao-Yuan Mo, Geng Xiong, Lin Zhang, Jia He, (unknown), Zhi‐Wei Liu, Qiu-Yan Chen, (unknown), Limin Zheng, Chao-Nan Qian, Yi-Xin Zeng	66
16	Prognostic significance of the various classifications for parapharyngeal space involvement in nasopharyngeal carcinoma 2012 ·Acta Oto-Laryngologica ·Pei‐Yu Huang, (unknown), Chuan-Miao Xie, Qiu-Yan Chen, Yue-Feng Wen, Juan Li, (unknown), Huai Liu, (unknown), Hai-Qiang Mai, Hao-Yuan Mo	4
17	Prognostic value and differences of the sixth and seventh editions of the UICC/AJCC staging systems in nasopharyngeal carcinoma 2012 ·Journal of Cancer Research and Clinical Oncology ·Rui Sun, (unknown), Hai-Qiang Mai, Qing Zhang, Ming‐Huang Hong, (unknown), Jing Yang, Jian Sun, Hao-Yuan Mo	29
18	Prognostic value of pretreatment and recovery duration of cranial nerve palsy in nasopharyngeal carcinoma 2012 ·Radiation Oncology ·Hao-Yuan Mo, Rui Sun, Jian Sun, Qing Zhang, (unknown), (unknown), Jing Yang, Hai-Qiang Mai	11
19	Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial 2011 ·JNCI Journal of the National Cancer Institute ·Qiu-Yan Chen, Yue-Feng Wen, Ling Guo, Huai Liu, Pei‐Yu Huang, Hao-Yuan Mo, (unknown), Yan‐Qun Xiang, Dong-Hua Luo, Fang Qiu, Rui Sun, (unknown), Ming‐Yuan Chen, Yi-Jun Hua, Xiang Guo, Ka-Jia Cao, Ming‐Huang Hong, Chao-Nan Qian, Hai-Qiang Mai	232
20	Endoscopic microwave coagulation therapy for early recurrent T1 nasopharyngeal carcinoma 2009 ·European Journal of Cancer ·Hai-Qiang Mai, Hao-Yuan Mo, (unknown), (unknown), Wei-Yuan Mai, (unknown), Xiang Guo, Ming‐Huang Hong	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact